Mao-Shin Lin
Latest contributions
TAVI and future coronary access - LIVE case
18 Feb 2024 – From PCR Tokyo Valves 2024
An 81-year-old woman, with a history of breast cancer surgery, stroke, and lymphoma remission, presented a severe symptomatic aortic stenosis associated with a suspicion of right coronary artery disease on the CT. The operators decided to perform TAVI first and then control the RCA by angiography...
Achieving the optimal outcome using the latest self-expandable TAVI - LIVE case
17 Feb 2024 – From PCR Tokyo Valves 2024
An 86-year-old woman presented severe symptomatic aortic stenosis and coronary artery disease with a preserved LV function. The operators performed a PCI of the RCA ostium one month ago. The CT showed a small femoral access (diameter: 5.3 to 4.9 mm).
After a predilatation with a 20 mm...
TAVI cases that I need to think more
18 May 2023 – From EuroPCR 2023
Consult this session if you want to optimise management of concomitant coronary artery disease and heart failure in TAVI patients, to predict, evaluate, and manage paravalvular leakage after TAVI, and to diagnose, manage, and prevent vascular complications in TAVI.
Challenging CTO procedures
18 May 2023 – From EuroPCR 2023
Witness these cases centered around chronic total occlusion procedures and develop expertise in the treatment of situations that often remain a challenge. Topics covered include -Retrograde and antererograde approach in patient with double CTO under IVUS guidance intervention- CTO PCI in multivessel coronary artery- Explore these...
TAVI in small annulus and coronary artery disease - Session with LIVE case
19 Feb 2023 – From PCR Tokyo Valves 2023
Watch the complex case of an 84-year-old woman with hypertension, type 2 diabetes and coronary artery disease who presented with worsening NYHA class II-III exertional dyspnoea, but no angina, and find out how she was treated LIVE.
TAVI and others
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about a study comparing the treatment's results of patients with bicuspid (BAV) and tricuspid aortic valve (TAV), in whom TAVI was performed, in terms of device success, early safety and clinical efficacy.
How to optimise coronary intervention therapy with SAPIEN 3
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn through various challenging cases about the optimal timing for performing coronary intervention for TAVI patients, the coronary access techniques for SAPIEN 3 patients and the differences in coronary access between balloon- and self-expandable devices.
